BeOne Medicines
ONC
#638
Rank
ยฃ27.50 B
Marketcap
ยฃ248.59
Share price
-1.91%
Change (1 day)
58.59%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ5.72 Billion

According to BeOne Medicines's latest financial reports the company's total assets are ยฃ5.72 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BeOne Medicines - Total assets on balance sheet (from 2014 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ4.71 B3.54%
2023-12-31ยฃ4.55 B-13.58%
2022-12-31ยฃ5.27 B-16.61%
2021-12-31ยฃ6.32 B53.89%
2020-12-31ยฃ4.10 B234.19%
2019-12-31ยฃ1.22 B-30.63%
2018-12-31ยฃ1.77 B128.89%
2017-12-31ยฃ0.77 B135.43%
2016-12-31ยฃ0.32 B317.41%
2015-12-31ยฃ78.79 M128.78%
2014-12-31ยฃ34.44 M381.53%
2013-12-31ยฃ7.15 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Onconova Therapeutics
ONTX
ยฃ13.63 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ1.49 B-73.86%๐Ÿ‡บ๐Ÿ‡ธ USA